Target intelligence / Profile preview

Echinoderm microtubule-associated protein-like 5 (EML5)

Target
EML5
Molecular classification
Other (cytoskeletal protein), WD40 repeat-containing protein, Microtubule-associated protein
01

Overview

Echinoderm microtubule-associated protein-like 5 (EML5) is a large, evolutionarily conserved cytoskeletal protein that contains multiple WD40 domains and hydrophobic EMAP-like protein (HELP) domains. These structural elements suggest a role in microtubule stabilization, modulation of their assembly dynamics, and interactions with other proteins. EML5 is expressed highly in the brain, particularly in the hippocampus, cerebellum, and olfactory bulb, and appears important in neuronal development and adult neural function. Like other members of the EMAP family, it likely regulates microtubule dynamics, impacting cytoskeletal rearrangements, especially in neural tissues. There are no drugs known to interact with EML5, it is not a classical therapeutic target, and there is no evidence implicating it directly as a disease biomarker or gene target in major diseases, although mutations are associated with lysosomal storage disorders such as Mucopolysaccharidosis IVB.

Other names
EMAP-like 5EMAP-5HuEMAP-2EMAP-2FAP16echinoderm microtubule-associated protein-like 5EML-5
02

Mechanism of action

Not applicable

03

Biological functions

Microtubule binding and modulation of microtubule assembly dynamicsCytoskeletal rearrangementLikely involvement in neuronal development and adult brain function
04

Disease associations

No direct evidence as a disease driver or therapeutic targetDisease association: Mucopolysaccharidosis, type IVBLikely involved in cytoskeletal regulation disorders (inference based on family function)

Beyond the preview

Go deeper on Echinoderm microtubule-associated protein-like 5 (EML5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Echinoderm microtubule-associated protein-like 5 (EML5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call